Evidence map›Paper›PMID 35425851›Full record

ArticleJournal of patient experience2022

Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey.

Susan Grandy, Eirini Palaka, Nicolas Guzman, Alicia Dunn, Eric T Wittbrodt, Fredric O Finkelstein

Open access · diamondAbstract read
In one paragraph

Article in Journal of patient experience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Susan GrandyBiopharmaceuticals Global Market Access, AstraZeneca, Gaithersburg, MD, USA.ORCID https://orcid.org/0000-0002-8030-5845
Eirini PalakaBiopharmaceuticals Global Market Access, AstraZeneca, Cambridge, UK.
Nicolas GuzmanGlobal Medicines Development, AstraZeneca, Gaithersburg, MD, USA.
Alicia DunnGlobal Corporate Affairs, AstraZeneca, Gaithersburg, MD, USA.
Eric T WittbrodtBiopharmaceuticals Medical Unit, AstraZeneca, Gaithersburg, MD, USA.ORCID https://orcid.org/0000-0002-4060-7638
Fredric O FinkelsteinYale University, New Haven, CT, USA.
AstraZeneca (United States) · USAstraZeneca (United Kingdom) · GBYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anemia in chronic kidney disease (CKD) is associated with reduced health-related quality of life and physical functioning. This study investigated knowledge and awareness of anemia in patients with CKD in the United States (US) through an online, quantitative survey administered to patients aged ≥18 years with self-reported CKD, with or without anemia. Of 446 patients included, 255 (57.2%) were diagnosed with anemia and 191 (42.8%) were in the non-anemia cohort. In patients with anemia, 71.0% were aware of the relationship between CKD and anemia versus 52.9% in the non-anemia cohort. In the anemia cohort, 46.3% of patients were aware of their hemoglobin level, versus 27.2% in the non-anemia cohort. Despite 67.4% of patients with anemia believing their condition was well/very well managed, only 50% reported being informed about different treatments without prompting healthcare providers. In the US, patients with anemia and CKD perceived that anemia had a negative impact on physical health and emotional wellbeing. Results emphasize a lack of disease awareness, suggesting patients would benefit from further education on anemia in CKD.

Indexed as

anemiachronic kidney diseasesurveyUS

Identifiers

PMID35425851
PMCPMC9003657
OpenAlexW4225788937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.